Evidence map›Paper›PMID 40061956›Full record

ReviewFrontiers in pharmacology2025

Sai Jiang, Mengyun Wang, Amanpreet Kaur, Lin Jiang, Yuan Cai, Jiangyi Luo, Minxi Li, Hongxing Wang, Dan Wan, Yanmei Peng

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sai Jiang *Institute of Innovative Traditional Chinese Medications, Hunan Academy of Chinese Medicine, Changsha, China.
Mengyun Wang *TCM and Ethnomedicine Innovation and Development International Laboratory, Innovative Material Medical Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, China.
Amanpreet KaurDepartment of Chemistry, School of Sciences, IFTM University, Moradabad, Uttar Pradesh, India.
Lin JiangTCM and Ethnomedicine Innovation and Development International Laboratory, Innovative Material Medical Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, China.
Yuan CaiInstitute of Innovative Traditional Chinese Medications, Hunan Academy of Chinese Medicine, Changsha, China.
Jiangyi LuoTCM and Ethnomedicine Innovation and Development International Laboratory, Innovative Material Medical Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, China.
Minxi LiInstitute of Innovative Traditional Chinese Medications, Hunan Academy of Chinese Medicine, Changsha, China.
Hongxing WangForestry Bureau of Hengnan County, Hengyang, China.
Dan WanInstitute of Innovative Traditional Chinese Medications, Hunan Academy of Chinese Medicine, Changsha, China.
Yanmei PengInstitute of Innovative Traditional Chinese Medications, Hunan Academy of Chinese Medicine, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Methods: Literatures related to Results: From 1980 to August 2024, only 101 compounds have been identified within this genus, primarily consisting of flavonoids, phenylpropanoids, phenolics, benzoquinones, triterpenoids, and fatty acids, with phenylpropanoids being the main components. Extracts and compounds from Conclusion: Research on the

Indexed as

clinical studiesEhretia genuspharmacologyphytochemistrytraditional uses

Identifiers

PMID40061956
PMCPMC11885236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.